Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.
Wu J, Henderson C, Feun L, Van Veldhuizen P, Gold P, Zheng H, Ryan T, Blaszkowsky LS, Chen H, Costa M, Rosenzweig B, Nierodzik M, Hochster H, Muggia F, Abbadessa G, Lewis J, Zhu AX.
Wu J, et al. Among authors: hochster h.
Invest New Drugs. 2010 Oct;28(5):670-6. doi: 10.1007/s10637-009-9286-9. Epub 2009 Jun 30.
Invest New Drugs. 2010.
PMID: 19565187
Clinical Trial.